Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
3 clinical trials · Condition
◉ Watch Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
| Record | Firm | Date |
|---|---|---|
| Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer (NCT00551070) | National Cancer Institute (NCI) | 2007-12-17 |
| Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors (NCT00301756) | National Cancer Institute (NCI) | 2006-09-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
Track Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.